Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration  Julio.

Slides:



Advertisements
Similar presentations
Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
Advertisements

Gastrulation Movements: the Logic and the Nuts and Bolts Maria Leptin Developmental Cell Volume 8, Issue 3, Pages (March 2005) DOI: /j.devcel
Risk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled.
Patterns of relapse and outcome of elderly multiple myeloma patients treated as front- line therapy with novel agents combinations  Aurelio Lopez, Maria-Victoria.
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group  Fernando Franco Pérez, Javier Lavernia, David Aguiar-Bujanda, José.
Martin Dreyling, MD, PhD  Seminars in Hematology 
Large-Cell Transformation of Mycosis Fungoides Occurring at the Site of Previously Treated Cutaneous B-Cell Lymphoma  Jennifer L. Herrmann, Naveed Sami 
Clinical Lymphoma, Myeloma and Leukemia
The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma  Kyung Ah Yoh, Ho Sup Lee,
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management  Jorge E. Cortes, Carlos.
Building better therapy for children with acute lymphoblastic leukemia
Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group  Fernando Franco Pérez, Javier Lavernia, David Aguiar-Bujanda, José.
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study 
The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower- Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005.
In Stem Cell Transplantation by Limiting the Morbidity of Graft-versus-Host Disease Tolerance to Myeloablative Conditioning is Improved  Nicolas Novitzky,
Yuji Nakamoto  Clinical Lymphoma, Myeloma and Leukemia 
Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data  Kathleen Lang,
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic.
The Epidemiology and Clinical Associations of Stroke in Patients With Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient.
Chronic Diarrhea Caused by Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma With Colorectal Involvement  Chencheng Xie, Khalil Aloreidi, Jorge.
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma,
Allogeneic Stem Cell Transplantation for Relapsed or Refractory Lymphoma after Conditioning with BEAM/Fludarabine/TBI  Alix O’Meara, Jörg Halter, Dominik.
Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients  Kaiguo Li, Ruyue Wang, Shiting Huang, Xinbin Pan, Hongmin.
Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics  Vincent T. Ma, Philip S. Boonstra,
Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care.
Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for.
Limited Utility of Surveillance Imaging for Detecting Disease Relapse in Patients With Non-Hodgkin Lymphoma in First Complete Remission  Quoc Truong,
A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B- cell Non-Hodgkin Lymphoma  Pallawi Torka, Priyank Patel, Wei Tan,
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective,
A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AML  Benyam Muluneh, Kaitlyn Buhlinger,
Subepithelial Corneal Immunoglobulin Deposition as a Manifestation of Multiple Myeloma: A Case Report and Literature Review  Trent P. Wang, Steven G.
Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience  AnnaLynn M. Williams, Andrea M. Baran, Carla Casulo,
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world.
Interim Functional Imaging Is an Independent Predictor of Progression-free Survival in Advanced Classical Hodgkin Lymphoma – A Real-world Analysis  Moussab.
Multiple Myeloma in Serologic Complete Remission after Autologous Stem Cell Transplantation: Impact of Bone Marrow Plasma Cell Assessment by Conventional.
Efficacy and Toxicity of Idarubicin Versus High-dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and.
Elotuzumab in Combination with Lenalidomide and Dexamethasone for Treatment- resistant Immunoglobulin Light Chain Amyloidosis With Multiple Myeloma  Shumaila.
Volume 26, Issue 2, Pages (February 2018)
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma  John M. Burke,
Vertebral Fracture Risk of Multiple Myeloma Assessed by a CT-based Finite Element and Trabecular Structure Analysis  Miyuki Takasu, Yoko Kaichi, Kazuo.
Severe Constipation Clinical Gastroenterology and Hepatology
Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature 
Hemophagocytic Lymphohistiocytosis in a Patient With Multiple Myeloma
Time to Insurance Approval in Private and Public Payers Does Not Influence Survival in Patients Who Undergo Hematopoietic Cell Transplantation  Vijaya.
Clinical and Disease Characteristics From REVEAL at Time of Enrollment (Baseline): Prospective Observational Study of Patients With Polycythemia Vera.
Clinical Lymphoma, Myeloma and Leukemia
Single-Agent Liposomal All-Trans-Retinoic Acid as Initial Therapy for Acute Promyelocytic Leukemia: 13-Year Follow-Up Data  Preetesh Jain, Hagop Kantarjian,
Practical Measures of Clinical Benefit With Ruxolitinib Therapy: An Exploratory Analysis of COMFORT-I  Carole B. Miller, Rami S. Komrokji, Ruben A. Mesa,
Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides  Francine Foss, Madeleine Duvic, Adam Lerner, Joel Waksman, Sean Whittaker 
A Post Hoc Sensitivity Analysis of Survival Probabilities in a Multinational Phase III Trial of Decitabine in Older Patients With Newly Diagnosed Acute.
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Sorafenib As Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid.
A Comparison of Long-Term Outcomes of Donor Lymphocyte Infusions and Tyrosine Kinase Inhibitors in Patients With Relapsed CML After Allogeneic Hematopoietic.
Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single- Institution Experience  Bolanle Gbadamosi, Daniel Ezekwudo, Sanjog Bastola,
Generic Imatinib Therapy Among Jordanians: An Observational Assessment of Efficacy and Safety in Routine Clinical Practice  Abdalla Awidi, Salah Abbasi,
Volume 17, Issue 2, Pages (February 1950)
Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review  Jill A. Bell, Aaron.
Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma  Stephen.
Large-Cell Transformation of Mycosis Fungoides Occurring at the Site of Previously Treated Cutaneous B-Cell Lymphoma  Jennifer L. Herrmann, Naveed Sami 
Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia,
Phase II Study of Vincristine Sulfate Liposome Injection (Marqibo) and Rituximab for Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma.
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
Clinical Lymphoma, Myeloma and Leukemia
Pure Erythroid Leukemia Presenting in a HIV-Positive Patient
Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?  Elias Jabbour, MD, Jorge E. Cortes,
Exercise in Individuals With CKD: A Focus Group Study Exploring Patient Attitudes, Motivations, and Barriers to Exercise  Jessica Kendrick, Michael Ritchie,
Autologous Stem Cell Transplantation for POEMS Syndrome
Presentation transcript:

Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration  Julio Delgado, Gabriela Ghita, Tycho Baumann, Rodrigo Santacruz, Ivan Dlouhy, Marta Aymerich, Maria Rozman, Natalia Creus, Arturo Pereira, Emili Montserrat  Clinical Lymphoma, Myeloma and Leukemia  Volume 14, Issue 1, Pages 73-79 (February 2014) DOI: 10.1016/j.clml.2013.08.003 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Overall Survival According to Treatment Group in (A) The Whole Cohort; (B) Patients With Binet Stage A Disease; (C) Patients With Binet Stage B Disease; and (D) Patients With Binet Stage C Disease at Frontline Therapy Abbreviations: PA = purine analogues; PA+R = PA plus rituximab. Clinical Lymphoma, Myeloma and Leukemia 2014 14, 73-79DOI: (10.1016/j.clml.2013.08.003) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Overall Survival for Patients Receiving Chemoimmunotherapy According to the Time of Administration. Front-Line (n = 55) vs. ≥ 1 Line (n = 59) Clinical Lymphoma, Myeloma and Leukemia 2014 14, 73-79DOI: (10.1016/j.clml.2013.08.003) Copyright © 2014 Elsevier Inc. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.